Literature DB >> 26546579

Signaling pathways regulating neuron-glia interaction and their implications in Alzheimer's disease.

Hong Lian1, Hui Zheng1,2.   

Abstract

Astrocytes are the most abundant cells in the central nervous system. They play critical roles in neuronal homeostasis through their physical properties and neuron-glia signaling pathways. Astrocytes become reactive in response to neuronal injury and this process, referred to as reactive astrogliosis, is a common feature accompanying neurodegenerative conditions, particularly Alzheimer's disease. Reactive astrogliosis represents a continuum of pathobiological processes and is associated with morphological, functional, and gene expression changes of varying degrees. There has been a substantial growth of knowledge regarding the signaling pathways regulating glial biology and pathophysiology in recent years. Here, we attempt to provide an unbiased review of some of the well-known players, namely calcium, proteoglycan, transforming growth factor β, NFκB, and complement, in mediating neuron-glia interaction under physiological conditions as well as in Alzheimer's disease. This review discusses the role of astrocytic NFκB and calcium as well as astroglial secreted factors, including proteoglycans, TGFβ, and complement in mediating neuronal function and AD pathogenesis through direct interaction with neurons and through cooperation with microglia.
© 2015 International Society for Neurochemistry.

Entities:  

Keywords:  Alzheimer's disease; NFκB; astrocytes; complement; microglia; neuron-glia interaction

Mesh:

Year:  2015        PMID: 26546579      PMCID: PMC4720533          DOI: 10.1111/jnc.13424

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  295 in total

Review 1.  The transforming growth factor-betas: structure, signaling, and roles in nervous system development and functions.

Authors:  M Böttner; K Krieglstein; K Unsicker
Journal:  J Neurochem       Date:  2000-12       Impact factor: 5.372

Review 2.  Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease.

Authors:  Frank M LaFerla
Journal:  Nat Rev Neurosci       Date:  2002-11       Impact factor: 34.870

Review 3.  Chondroitin sulphate proteoglycans in the central nervous system: changes and synthesis after injury.

Authors:  F Properzi; R A Asher; J W Fawcett
Journal:  Biochem Soc Trans       Date:  2003-04       Impact factor: 5.407

Review 4.  Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection.

Authors:  Gregor Zündorf; Georg Reiser
Journal:  Antioxid Redox Signal       Date:  2010-10-06       Impact factor: 8.401

Review 5.  Disentangling calcium-driven astrocyte physiology.

Authors:  Dmitri A Rusakov
Journal:  Nat Rev Neurosci       Date:  2015-03-11       Impact factor: 34.870

6.  IKKβ deficiency in myeloid cells ameliorates Alzheimer's disease-related symptoms and pathology.

Authors:  Yang Liu; Xu Liu; Wenlin Hao; Yann Decker; Robert Schomburg; Livia Fülöp; Manolis Pasparakis; Michael D Menger; Klaus Fassbender
Journal:  J Neurosci       Date:  2014-09-24       Impact factor: 6.167

7.  Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate.

Authors:  J D Rothstein; M Dykes-Hoberg; C A Pardo; L A Bristol; L Jin; R W Kuncl; Y Kanai; M A Hediger; Y Wang; J P Schielke; D F Welty
Journal:  Neuron       Date:  1996-03       Impact factor: 17.173

Review 8.  Scar-mediated inhibition and CSPG receptors in the CNS.

Authors:  Kartavya Sharma; Michael E Selzer; Shuxin Li
Journal:  Exp Neurol       Date:  2012-07-24       Impact factor: 5.330

Review 9.  Neuroinflammation in Alzheimer's disease.

Authors:  Michael T Heneka; Monica J Carson; Joseph El Khoury; Gary E Landreth; Frederic Brosseron; Douglas L Feinstein; Andreas H Jacobs; Tony Wyss-Coray; Javier Vitorica; Richard M Ransohoff; Karl Herrup; Sally A Frautschy; Bente Finsen; Guy C Brown; Alexei Verkhratsky; Koji Yamanaka; Jari Koistinaho; Eicke Latz; Annett Halle; Gabor C Petzold; Terrence Town; Dave Morgan; Mari L Shinohara; V Hugh Perry; Clive Holmes; Nicolas G Bazan; David J Brooks; Stéphane Hunot; Bertrand Joseph; Nikolaus Deigendesch; Olga Garaschuk; Erik Boddeke; Charles A Dinarello; John C Breitner; Greg M Cole; Douglas T Golenbock; Markus P Kummer
Journal:  Lancet Neurol       Date:  2015-04       Impact factor: 44.182

Review 10.  Astrocyte calcium waves: what they are and what they do.

Authors:  Eliana Scemes; Christian Giaume
Journal:  Glia       Date:  2006-11-15       Impact factor: 8.073

View more
  16 in total

1.  An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer's disease.

Authors:  Anamitra Ghosh; Michele M Comerota; Debin Wan; Fading Chen; Nicholas E Propson; Sung Hee Hwang; Bruce D Hammock; Hui Zheng
Journal:  Sci Transl Med       Date:  2020-12-09       Impact factor: 17.956

2.  Calmodulin modulates the Ca2+-dependent inactivation and expression level of bovine CaV2.2 expressed in HEK293T cells.

Authors:  Chih-Hung Chi; Chih-Yung Tang; Chien-Yuan Pan
Journal:  IBRO Rep       Date:  2017-03-18

Review 3.  Contribution of Neurons and Glial Cells to Complement-Mediated Synapse Removal during Development, Aging and in Alzheimer's Disease.

Authors:  Celia Luchena; Jone Zuazo-Ibarra; Elena Alberdi; Carlos Matute; Estibaliz Capetillo-Zarate
Journal:  Mediators Inflamm       Date:  2018-11-11       Impact factor: 4.711

4.  Is Alzheimer's Also a Stem Cell Disease? - The Zebrafish Perspective.

Authors:  Caghan Kizil; Prabesh Bhattarai
Journal:  Front Cell Dev Biol       Date:  2018-11-23

Review 5.  Microglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets.

Authors:  Sohaib Nizami; Hazel Hall-Roberts; Sharat Warrier; Sally A Cowley; Elena Di Daniel
Journal:  Br J Pharmacol       Date:  2019-05-11       Impact factor: 8.739

6.  Liver Growth Factor Induces Glia-Associated Neuroprotection in an In Vitro Model of Parkinson´s Disease.

Authors:  Rafael Gonzalo-Gobernado; Diana Reimers; María José Casarejos; Lucía Calatrava Ferreras; Manuela Vallejo-Muñoz; Adriano Jiménez-Escrig; Juan José Diaz-Gil; Gonzalo M Ulzurrun de Asanza; Eulalia Bazán
Journal:  Brain Sci       Date:  2020-05-22

Review 7.  Autophagy and Redox Homeostasis in Parkinson's: A Crucial Balancing Act.

Authors:  Natalia Jimenez-Moreno; Jon D Lane
Journal:  Oxid Med Cell Longev       Date:  2020-11-10       Impact factor: 6.543

8.  Mechanisms of neuroplasticity and brain degeneration: strategies for protection during the aging process.

Authors:  Mariana Toricelli; Arthur Antonio Ruiz Pereira; Guilherme Souza Abrao; Helena Nascimento Malerba; Julia Maia; Hudson Sousa Buck; Tania Araujo Viel
Journal:  Neural Regen Res       Date:  2021-01       Impact factor: 5.135

9.  Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer's disease transgenic mouse model.

Authors:  Jackie K Y Lau; Min Tian; Yang Shen; Shun-Fat Lau; Wing-Yu Fu; Amy K Y Fu; Nancy Y Ip
Journal:  Sci Rep       Date:  2021-02-23       Impact factor: 4.379

Review 10.  Astrocytes in Alzheimer's Disease: Pathological Significance and Molecular Pathways.

Authors:  Pranav Preman; Maria Alfonso-Triguero; Elena Alberdi; Alexei Verkhratsky; Amaia M Arranz
Journal:  Cells       Date:  2021-03-04       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.